Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow scintigraphy in prostatic carcinomas.

P Bourgeois1, M Malarme, R Van Franck

  • 1C.H.J. Bracops, Department of Nuclear Medicine, Université Libre de Bruxelles, Belgium.

Nuclear Medicine Communications
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation Des Cephalosporins De La Deuxieme Generation: Cefamandole, Cefoxitine, Cefuroxime.

Acta clinica Belgica·2016
Same author

Consumption of hair dye products by the French women population: Usage pattern and exposure assessment.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2016
Same author

Fluorescence imaging after intraoperative intravenous injection of indocyanine green for detection of lymph node metastases in colorectal cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2015
Same author

Pericallosal aneurysm: A difficult challenge for microsurgery and endovascular treatment.

Neuro-Chirurgie·2015
Same author

Contamination of freshly slaughtered pig carcasses with enteropathogenic Yersinia spp.: Distribution, quantification and identification of risk factors.

International journal of food microbiology·2015
Same author

Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients.

European journal of pain (London, England)·2014
Same journal

Diagnostic performance and quantitative characterization of PET/computed tomography in peritoneal deposits assessment.

Nuclear medicine communications·2026
Same journal

Diagnostic value of dual-time-point 18F-fluorodeoxyglucose PET/computed tomography in differentiating benign and malignant extrahepatic bile duct occupying lesions.

Nuclear medicine communications·2026
Same journal

Prognostic value of baseline 18F- fluroodexoygloucose PET/computed tomography-derived maximum standardized uptake value and tumor bulk in pediatric Hodgkin lymphoma: a retrospective analysis.

Nuclear medicine communications·2026
Same journal

A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging.

Nuclear medicine communications·2026
Same journal

Prediction of tumor radiation absorbed dose in radionuclide therapy based on the mean standardized uptake value from PET imaging.

Nuclear medicine communications·2026
Same journal

Serum cytokine profiles in papillary thyroid carcinoma patients with lung metastases: characteristics and the relationship with prognosis.

Nuclear medicine communications·2026
See all related articles

Bone marrow scintigraphy (MS) is less sensitive than bone scintigraphy (BS) for diagnosing prostate cancer bone metastases but offers higher specificity. MS is valuable for dubious BS results and monitoring treatment response.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • Prostate carcinoma frequently metastasizes to bone.
  • Accurate detection and monitoring of skeletal metastases are crucial for patient management.

Purpose of the Study:

  • To compare the diagnostic performance of bone marrow scintigraphy (MS) with conventional bone scintigraphy (BS) in patients with prostate cancer.
  • To evaluate the utility of MS in assessing treatment response in skeletal metastases.

Main Methods:

  • Bone marrow scintigrams (MS) were performed on 73 men with prostate cancer.
  • Results were compared with conventional bone scintigraphy (BS) and clinical/radiological data.
  • Follow-up data were analyzed for diagnostic accuracy and treatment response evaluation.

Related Experiment Videos

Main Results:

  • MS showed lower sensitivity (83-94%) compared to BS (86-100%) for diagnosing skeletal metastases.
  • MS demonstrated higher specificity (81-87%) than BS (73-100%) under different criteria.
  • MS was useful in cases with equivocal BS findings and for monitoring treatment response, proving better or equivalent to BS in 10 out of 11 cases.

Conclusions:

  • Bone marrow scintigraphy (MS) is a valuable adjunct to bone scintigraphy (BS) for prostate cancer patients with suspected skeletal metastases.
  • MS aids in clarifying ambiguous BS results and effectively monitors therapeutic response.
  • MS is a useful tool for evaluating the evolution of skeletal metastases during treatment.